• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由硬脂酸和胱胺组成的固体脂质纳米粒的还原响应释放

Reduction-Responsive Release of Solid Lipid Nanoparticle Composed of Stearic Acid and Cystamine.

作者信息

Kwon Kyeongnan, Kim Jin-Chul

机构信息

Department of Medical Biomaterials Engineering, College of Biomedical Science and Institute of Bioscience and Biotechnology, Kangwon National University, 192-1, Hyoja 2 dong, Chuncheon, Kangwon-do 20-701, Republic of Korea.

出版信息

J Nanosci Nanotechnol. 2018 May 1;18(5):3102-3109. doi: 10.1166/jnn.2018.14690.

DOI:10.1166/jnn.2018.14690
PMID:29442809
Abstract

A reduction-responsive solid lipid nanoparticles (SLNs) were prepared by an emulsification evaporation and solidification method using stearic acid (SA) and cystamine as constituting materials. The mean hydrodynamic diameter of the SLN decreased from 510.6 nm to 117.0 nm, as the molar ratio of SA to cystamine increased from 1:0 to 1:1. On the TEM photo, negatively stained SLNs were found as black circles and the diameter was tens to hundreds of nanometer. According to the EDS analysis, the sulfur content of SLN was found to be 1.19% (w/w) to 3.62% (w/w), depending on the molar ratio of SA to cystamine (1:0.125 to 1:1) employed in the preparation. According to the differential scanning calorimetric analysis, the melting point decreased gradually from about 52 °C to 50 °C as the molar ratio of SA to cystamine increased from 1:0 to 1:1. Even if cystamine (a disulfide compound) was contained in SLN, the release degree at 25 °C was not significantly affected by dithiothreitol (DTT, a reducing agent). Whereas, the release degree at 37 °C and 52 °C was significantly suppressed by DTT when cystamine was contained in SLN, possibly because cystamine would be more readily reduced to aminoethanethiols in the SLN matrix at the higher temperatures.

摘要

以硬脂酸(SA)和胱胺为构成材料,通过乳化蒸发固化法制备了一种还原响应型固体脂质纳米粒(SLN)。随着SA与胱胺的摩尔比从1:0增加到1:1,SLN的平均流体动力学直径从510.6 nm降至117.0 nm。在透射电镜照片上,负染色的SLN呈黑色圆圈,直径为几十到几百纳米。根据能谱分析,根据制备中使用的SA与胱胺的摩尔比(1:0.125至1:1),SLN的硫含量为1.19%(w/w)至3.62%(w/w)。根据差示扫描量热分析,随着SA与胱胺的摩尔比从1:0增加到1:1,熔点从约52℃逐渐降至50℃。即使SLN中含有胱胺(一种二硫化物化合物),25℃下的释放程度也不受二硫苏糖醇(DTT,一种还原剂)的显著影响。然而,当SLN中含有胱胺时,37℃和52℃下的释放程度受到DTT的显著抑制,这可能是因为在较高温度下,胱胺在SLN基质中更容易还原为氨基乙硫醇。

相似文献

1
Reduction-Responsive Release of Solid Lipid Nanoparticle Composed of Stearic Acid and Cystamine.由硬脂酸和胱胺组成的固体脂质纳米粒的还原响应释放
J Nanosci Nanotechnol. 2018 May 1;18(5):3102-3109. doi: 10.1166/jnn.2018.14690.
2
Redox-responsive alginate microsphere containing cystamine.
J Biomater Sci Polym Ed. 2016 Oct;27(15):1520-33. doi: 10.1080/09205063.2016.1215800. Epub 2016 Aug 8.
3
Characterization of ergocalciferol loaded solid lipid nanoparticles.维生素 D2 载入固体脂质纳米粒的特性研究。
J Food Sci. 2012 Jan;77(1):N8-13. doi: 10.1111/j.1750-3841.2011.02517.x.
4
Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery.用于眼部给药的载伊曲康唑固体脂质纳米粒的研制与表征
Pharm Dev Technol. 2015 Jun;20(4):458-64. doi: 10.3109/10837450.2014.882935. Epub 2014 Feb 4.
5
Redox-responsive solid lipid microparticles composed of octadecyl acrylate and allyl disulfide.基于丙烯酸十八酯和二烯丙基二硫的氧化还原响应性固体脂质毫微粒。
J Biomater Sci Polym Ed. 2018 Apr;29(5):476-490. doi: 10.1080/09205063.2017.1422854. Epub 2018 Jan 8.
6
Influence of precursor solvent properties on matrix crystallinity and drug release rates from nanoparticle aerosol lipid matrices.前体溶剂性质对纳米颗粒气溶胶脂质基质中基质结晶度和药物释放速率的影响。
Int J Pharm. 2012 Jul 1;430(1-2):228-37. doi: 10.1016/j.ijpharm.2012.03.030. Epub 2012 Mar 23.
7
[Orthogonal experiments for optimizing the formulation and preparation conditions of temozolomide solid lipid nanoparticles].用于优化替莫唑胺固体脂质纳米粒处方及制备条件的正交试验
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2008 Oct;25(5):1141-5.
8
Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.脂质基质对载奥氮平固体脂质纳米粒的药物包封率、体外释放及物理稳定性影响的研究
AAPS PharmSciTech. 2007 Oct 12;8(4):E83. doi: 10.1208/pt0804083.
9
Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers.脂质纳米载体增强免疫抑制大鼠丁香酚的抗真菌活性。
Colloids Surf B Biointerfaces. 2011 Oct 15;87(2):280-8. doi: 10.1016/j.colsurfb.2011.05.030. Epub 2011 May 26.
10
Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.含有混合脂质核心和极性异质脂质的固体脂质纳米分散体:表征
Eur J Pharm Biopharm. 2007 Aug;67(1):48-57. doi: 10.1016/j.ejpb.2006.12.004. Epub 2006 Dec 16.